Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Sepsis-Associated Acute Kidney Injury
NCT06570187Phase 4Recruiting
- Sponsor
- Cairo University
- Start
- Oct 2024
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in sepsis-associated acute kidney injury (S-AKI), sponsored by Cairo University. Started Oct 2024; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
sepsis-associated acute kidney injury (S-AKI)
Beyond the preview
Go deeper on NCT06570187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06570187.